Veeva Systems (NYSE: VEEV) and NantHealth (NASDAQ:NH) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.
This is a breakdown of recent ratings and recommmendations for Veeva Systems and NantHealth, as provided by MarketBeat.com.
||Strong Buy Ratings
Veeva Systems currently has a consensus target price of $67.70, indicating a potential upside of 7.70%. NantHealth has a consensus target price of $9.00, indicating a potential upside of 161.63%. Given NantHealth’s stronger consensus rating and higher probable upside, analysts plainly believe NantHealth is more favorable than Veeva Systems.
Institutional & Insider Ownership
70.8% of Veeva Systems shares are owned by institutional investors. Comparatively, 7.1% of NantHealth shares are owned by institutional investors. 17.5% of Veeva Systems shares are owned by company insiders. Comparatively, 58.0% of NantHealth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
This table compares Veeva Systems and NantHealth’s net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Valuation & Earnings
This table compares Veeva Systems and NantHealth’s gross revenue, earnings per share (EPS) and valuation.
||Earnings Per Share
Veeva Systems has higher revenue and earnings than NantHealth. NantHealth is trading at a lower price-to-earnings ratio than Veeva Systems, indicating that it is currently the more affordable of the two stocks.
Veeva Systems beats NantHealth on 10 of the 13 factors compared between the two stocks.
Veeva Systems Company Profile
Veeva Systems Inc. (Veeva) is a provider of cloud-based software solutions for the global life sciences industry. The Company offers solutions for a range of requirements within life sciences companies, including multichannel customer relationship management, regulated content and information management, master data management and customer data. The Company offers solutions to areas, including the Veeva CRM family of applications for multichannel customer relationship management to enable coordinated and personalized customer engagement through multiple touch points; Veeva Vault for regulated content management and information management solutions to enable the management of content-centric processes; the Veeva Network master data management solutions for the management of customer master and product master data, and Veeva’s data and data services offerings, including Veeva OpenData for customer reference data and Veeva KOL Data for data.
NantHealth Company Profile
NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.